Paris, July 31, 2026 – Jeantet advised Iris Ventures in its strategic investment in Krème, France’s leading dermocosmetics brand pioneering microbiome-powered skincare, fueling its next phase of growth.
Founded in 2020 by Juliette Lailler and Marie Belile, Krème pioneers microbiome-based skincare for sensitive skin, combining probiotic ferments with pharmaceutical rigor in natural, high-tolerance formulas made in France. With a range of over 35 products anchored by anti-aging bestsellers, the brand has expanded its science-driven approach into sun care and makeup through a disciplined “less but better” strategy.
The Jeantet team was led by Karl Hepp de Sevelinges (Partner, M&A/Corporate) and Georges-Dominic Sardi (Counsel, M&A/Venture Capital) and comprised François Peltre and Clara Sourin (Associates, M&A/Corporate), Delphine Baudouin (Partner, Banking/Finance), Andrei Radu (Associate, Banking/Finance), Chloé Chircop (Associate, IP/IT and GDPR), Marie Trébuchet (Associate, Employment), Chloé Strasser (Partner, Real Estate) and Neda Tassoubi (Counsel, Real Estate).
Download the press release





